Information regarding transfer of shares in Ascelia Pharma AB from CMC SPV
Ascelia Pharma AB (publ) (ticker: ACE) (“Ascelia Pharma” or the “Company”) today announced that it has been informed of that CMC SPV of 3 April 2017 AB (“CMC SPV”) today has divested 687,606 shares in the Company in a private placement to institutional investors and distributed 2,250,000 shares in the Company to its shareholders, including Sunstone and certain members of the board of directors and management of Ascelia Pharma. Following the transaction, CMC SPV no longer holds any shares in the Company.As disclosed in the prospectus issued by Ascelia Pharma in connection with the listing on